NCT04429932View on ClinicalTrials.gov

A Study to Evaluate Nicotine Uptake and Biomarkers in Adult Smokers Using mybluTM Electronic Cigarettes

NACompletedINTERVENTIONAL
Enrollment

39

Participants

Timeline

Start Date

December 1, 2019

Primary Completion Date

January 31, 2020

Study Completion Date

January 31, 2020

Conditions
Healthy Volunteers
Interventions
OTHER

Myblu flavor A_2.4

Use of Myblu e-cigarette with flavor 1 at 2.4% nicotine

OTHER

Myblu flavor B_2.4

Use of Myblu e-cigarette with flavor 2 at 2.4% nicotine

OTHER

Myblu flavor C_2.4

Use of Myblu e-cigarette with flavor C at 2.4% nicotine

OTHER

Myblu flavor D_2.4

Use of Myblu e-cigarette with flavor D at 2.4% nicotine

OTHER

Myblu flavor E_1.2

Use of Myblu e-cigarette with flavor 1 at 1.2% nicotine

OTHER

Myblu flavor F_1.2

Fse of Myblu e-cigarette with flavor F at 1.2% nicotine

OTHER

Myblu flavor G_2.4

Use of Myblu e-cigarette with flavor G at 2.4% nicotine

OTHER

Myblu flavor H_2.4

Use of Myblu e-cigarette with flavor H at 2.4% nicotine

Trial Locations (1)

68502

Celerion, Lincoln

All Listed Sponsors
collaborator

Fontem Ventures BV

INDUSTRY

lead

Fontem US LLC

INDUSTRY

NCT04429932 - A Study to Evaluate Nicotine Uptake and Biomarkers in Adult Smokers Using mybluTM Electronic Cigarettes | Biotech Hunter | Biotech Hunter